PharmaShots | Incisive News in 3 Shots

Subscribe Now

Tonix

Tonix Reports the First Patient Enrollment in the P-II Study (PREVENTION) of TNX-1900 for the Prevention of Migraine Headaches in Chronic Migraineurs

Tonix Reports the First Patient Enrollment in the P-II Study (PREVENTION) of TNX-1900 for the Prevention of Migraine Headaches in...

February 7, 2023

Tonix Signs a Research Agreement with University of Maryland to Develop TNX-1500 for the Prevention of Rejection in Heart Xenograft Transplantation in Animals

Tonix Signs a Research Agreement with University of Maryland to Develop TNX-1500 for the Prevention of Rejection in Heart Xenograf...

February 2, 2023

Tonix Reports the First Patient Enrollment in the P-III (RESILIENT) Study of TNX-102 SL for the Management of Fibromyalgia

Tonix Reports the First Patient Enrollment in the P-III (RESILIENT) Study of TNX-102 SL for the Management of Fibromyalgia

April 8, 2022

Tonix Reports Results of TNX-102 SL in P-III (RALLY) Study for the Treatment of Fibromyalgia

Tonix Reports Results of TNX-102 SL in P-III (RALLY) Study for the Treatment of Fibromyalgia

March 22, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us